Health Catalyst Reports First Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Health Catalyst Inc. (HCAT) PT Lowered to $42 at Goldman Sachs
May 11, 2022 6:55 AM EDTGoldman Sachs analyst Cindy Motz lowered the price target on Health Catalyst Inc. (NASDAQ: HCAT) to $42.00 (from $49.00) while maintaining a Buy rating.
The analyst commented, "Health Catalyst posted a good earnings report with revenue growth in the range of 24% year over year, and surprising the market with positive... More
